Prognostic Factors of Tuberculous Meningitis in Adults: A 6-Year Retrospective Study at a Tertiary Hospital in Northern Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 43, Issue 2, 2010, Pages 111-118

  Hsu, Po Chang ^a   Yang, Chien Chang ^a   Ye, Jung Jr ^a   Huang, Po Yen ^a   Chiang, Ping Cherng ^a   Lee, Ming Hsun ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

hydrocephalus; prognostic factors; steroid; tuberculous meningitis

Indexed keywords

CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; MANNITOL; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; STEROID; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CEREBROSPINAL FLUID; CLINICAL EVALUATION; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; HYDROCEPHALUS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NEUROIMAGING; POLYMERASE CHAIN REACTION; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SENESCENCE; SURVIVAL RATE; TAIWAN; TERTIARY HEALTH CARE; THORAX RADIOGRAPHY; TUBERCULOUS MENINGITIS;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; CEREBROSPINAL FLUID; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROGNOSIS; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; TUBERCULOSIS, MENINGEAL;

EID: 77951792258     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1684-1182(10)60018-7     Document Type: Article

References (24)

1. World Health Organization. Global tuberculosis control-surveillance, planning, financing. WHO report 2008. Available at: http://www.who.int/tb/publications/global_report/en [Date Accessed: February 3, 2009]
2. Sutlas P.N., Unal A., Forta H., Senol S., and Kirbas D. Tuberculous meningitis in adults: review of 61 cases. Infection 31 (2003) 387-391
3. Roca B., Tornador N., and Tornador E. Presentation and outcome of tuberculous meningitis in adults in province of Castellon, Spain: a retrospective study. Epidemiol Infect 136 (2008) 1455-1462
4. Qureshi H.U., Merwat S.N., Nawaz S.A., Rana A.A., Malik A., Mahmud M.K., et al. Predictors of inpatient mortality in 190 adult patients with tuberculous meningitis. J Pak Med Assoc 52 (2002) 159-163
5. Wang J.T., Hung C.C., Sheng W.H., Wang J.Y., Chang S.C., and Luh K.T. Prognosis of tuberculous meningitis in adults in the era of modern antituberculous chemotherapy. J Microbiol Immunol Infect 35 (2002) 215-222
6. Lu C.H., Chang W.N., and Chang H.W. The prognostic factors of adult tuberculous meningitis. Infection 29 (2001) 299-304
7. Misra U.K., Kalita J., Srivastava M., and Mandal S.K. Prognosis of tuberculous meningitis: a multivariate analysis. J Neurol Sci 137 (1996) 57-61
8. Grygorczuk S., Pancewicz S., Zajkowska J., Kondrusik M., and Hermanowska-Szpakowicz T. Tuberculous meningitis in 8-year observation of the Department of Infectious Diseases and Neuroinfections of the Medical Academy in Bialystok. Neurol Neurochir Pol 38 (2004) 31-36
9. Hosoglu S., Geyik M.F., Balik I., Aygen B., Erol S., Aygencel S.G., et al. Tuberculous meningitis in adults in Turkey: epidemiology, diagnosis, clinic and laboratory. Eur J Epidemiol 18 (2003) 337-343
10. Bhigjee A.I., Padayachee R., Paruk H., Hallwirth-Pillay K.D., Marais S., and Connoly C. Diagnosis of tuberculous meningitis: clinical and laboratory parameters. Int J Infect Dis 11 (2007) 348-354
11. Girgis N.I., Farid Z., Kilpatrick M.E., Sultan Y., and Mikhail I.A. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J 10 (1991) 179-183
12. Thwaites G.E., Nguyen D.B., Nguyen H.D., Hoang T.Q., Do T.T., Nguyen T.C., et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351 (2004) 1741-1751
13. Byrd T.F., and Davis L.E. Multidrug-resistant tuberculous meningitis. Curr Neurol Neurosci Rep 7 (2007) 470-475
14. Ahuja G.K., Mohan K.K., Prasad K., and Behari M. Diagnostic criteria for tuberculous meningitis and their validation. Tuber Lung Dis 75 (1994) 149-152
15. Streptomycin treatment of tuberculous meningitis. Lancet 1 (1948) 582-596
16. Kent S.J., Crowe S.M., Yung A., Lucas C.R., and Mijch A.M. Tuberculous meningitis: a 30-year review. Clin Infect Dis 17 (1993) 987-994
17. Hosoglu S., Ayaz C., Geyik M.F., Kokoglu O.F., and Ceviz A. Tuberculous meningitis in adults: an eleven-year review. Int J Tuberc Lung Dis 2 (1998) 553-557
18. Chiang I.H., Yu M.C., Bai K.J., Wu M.D., Hsu C.J., Lin T.P., et al. Drug resistance patterns of tuberculosis in Taiwan. J Formos Med Assoc 97 (1998) 581-583
19. Ozates M., Kemaloglu S., Gurkan F., Ozkan U., Hosoglu S., and Simsek M.M. CT of the brain in tuberculous meningitis. A review of 289 patients. Acta Radiol 41 (2000) 13-17
20. Sil K., and Chatterjee S. Shunting in tuberculous meningitis: a neurosurgeon's nightmare. Childs Nerv Syst 24 (2008) 1029-1032
21. Palur R., Rajshekhar V., Chandy M.J., Joseph T., and Abraham J. Shunt surgery for hydrocephalus in tuberculous meningitis: a long-term follow-up study. J Neurosurg 74 (1991) 64-69
22. Lamprecht D., Schoeman J., Donald P., and Hartzenberg H. Ventriculoperitoneal shunting in childhood tuberculous meningitis. Br J Neurosurg 15 (2001) 119-125
23. Simmons C.P., Thwaites G.E., Quyen N.T., Chau T.T., Mai P.D., Dung N.T., et al. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses. J Immunol 175 (2005) 579-590
24. Schoeman J.F., Elshof J.W., Laubscher J.A., Janse van Rensburg A., and Donald P.R. The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis. Ann Trop Paediatr 4 (2001) 299-305